OSR Health clarifies Nasdaq did not approve or endorse CVR program; record date Aug 14 unchanged

OSR Holdings, Inc.

On Aug 7, 2026, OSR Health issued clarification regarding its July 31, 2026 press release on Nasdaq and Shareholder Loyalty CVR program.
Nasdaq's earlier communication was preliminary verbal, limited to technical question of mechanical price adjustment (e.g., ex-date).
Nasdaq has not expressed any definitive opinion on the CVR program; prior statement should not imply approval or endorsement.
Record date for CVR program remains August 14, 2026; program details and enrollment unchanged at www.osr-health.com/loyaltyprogram.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.